Browse drugs

…ection of hyperglycemia—signals a need for caution in fluid and insulin titration protocols. Yet, without consistent data on management…

…ined as diet alone or oral agents with no risk of hypoglycemia (metformin, dipeptidyl peptidase-4 inhibitors and sodium–glucose cotranspo…

…0272) at flash intensity of 9.95 cd·s/m2 as shown in figure 1E. Suvorexant treatment produced an upward trend in b-wave implicit time unde…

…bdominal pain, nausea and vomiting, 15 days after initiation of tirzepatide. On admission, he was severely dehydrated with profound high-an…

…, ZnT8 autoantibodies declined (68.0% vs 71.9%, p=0.002), while insulin autoantibodies remained unchanged (p=0.06). Prevalence of IA2, …

…surance Institution of Finland using special reimbursements for insulin medication. The inclusion criteria covered individuals aged 0 t…

… be conducted to evaluate the efficacy and safety of the use of insulin eye-drops in the treatment of PED.Methods and analysis A presel…

…ng disabilities had better glycemic control but shorter time to insulin initiation. This may be related to more frequent diabetes monit…

…s that the appropriate widespread acclaim for the ‘discovery of insulin’ overlooks significant challenges, and while death was averted,…

…oncentrations, and similar observations have been reported with retatrutide despite its glucagon receptor agonist activity.9 Whether these …

…ups, with critical underdetection in NH Asian adults harbouring insulin- and inflammation-mediated fibrosis pathways invisible to BMI-c…

… concentrations of C-peptide (0.36 ng/ml vs 0.7ng/ml; p=0.003), insulin (639 pg/ml vs 2037pg/ml; p=0.0001) and GLP-2 (0 ng/ml vs 2.3ng/…